Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers

Journal of Molecular Modeling

Volumn 16, Issue 10, 2010, Pages 1585-1596

  Mitra, Indrani ^a   Saha, Achintya ^b   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Antioxidant; Benzo b thiophene; Pharmacophore; QSAR

Indexed keywords

BENZOTHIOPHENE; SCAVENGER;

ANTIOXIDANT ACTIVITY; ARTICLE; CONFIDENCE INTERVAL; CONFORMATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; HYDROGEN BOND; PHARMACOPHORE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

COMPUTATIONAL BIOLOGY; FREE RADICAL SCAVENGERS; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SOFTWARE; THIOPHENES;

EID: 77958059491     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-010-0661-4     Document Type: Article

References (40)

1. Genestra M (2007) Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807-1819
2. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
3. Bayol-Denizot C, Daval J-L, Netter P, Minn A (2000) Xenobioticmediated production of superoxide by primary cultures of rat cerebral endothelial cells, astrocytes, and neurons. Biochim Biophys Acta-Mol Cell Res 1497:115-126
4. Gutteridge JMC, Halliwell B (1994) Antioxidants in nutrition, health and disease. Oxford University Press, Oxford
5. Wright JS, Johnson ER, DiLabio GA (2001) Predicting the activity of phenolic antioxidants: theoretical method, analysis of substituent effects, and application to major families of antioxidants. J Am Chem Soc 123:1173-1183
6. Vafiadis AP, Bakalbassis EG (2005) A DFT study on the deprotonation antioxidant mechanistic step of ortho-substituted phenolic cation radicals. Chem Phys 316:195-204
7. Musialik M, Litwinienko G (2005) Scavenging of dpph• radicals by vitamin E is accelerated by its partial ionization: the role of sequential proton loss electron transfer. Org Lett 7:4951-4954
8. Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN (2008) Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem 8:1628-1655
9. Gonzalez MP, Teran C, Saiz-Urra L, Teijeira M (2008) Variable selection methods in QSAR: an overview. Curr Top Med Chem 8:1606-1627
10. Ray S, Sengupta C, Roy K (2007) QSAR modeling of antiradical and antioxidant activities of flavonoids using electrotopological state (E-State) atom parameters. Cent Eur J Chem 5:1094-1113
11. Ray S, Sengupta C, Roy K (2008) QSAR modeling for lipid peroxidation inhibition of flavonoids using topological and structural parameters. Cent Eur J Chem 6:267-276
12. Roy K, Mitra I, Saha A (2009) Molecular shape analysis of antioxidant and squalene synthase inhibitory activities of aromatic tetrahydro-1, 4-oxazine derivatives. Chem Biol Drug Des 74:507-516
13. Rastija V, Medic-Saric M (2009) QSAR study of antioxidant activity of wine polyphenols. Eur J Med Chem 44:400-408
14. Gupta S, Matthew S, Abreu PM, Aires-de-Sousa J (2006) QSAR analysis of phenolic antioxidants using MOLMAP descriptors of local properties. Bioorgan Med Chem 14:1199-1206
15. Roy K, Mitra I (2009) Advances in quantitative structure-activity relationship models of antioxidants. Expert Opin Drug Discov 4:1157-1175
16. Wermuth CG, Langer T (2000) Pharmacophore identification. In: Kubinyi H (ed) 3D QSAR in drug design: theory, methods and applications. Kluwer, Dordrecht, pp 117-149
17. Abreu RMV, Ferreira ICFR, Queiroz MRP (2009) QSAR model for predicting radical scavenging activity of di (hetero) arylamines derivatives of benzo[b]thiophenes. Eur J Med Chem 44:1952-1958
18. Accelrys Inc. (2010) Discovery Studio 2.1. Accelrys Inc., San Diego
19. Esteves MA, Narender N, Marcelo-Curto MJ, Gigante B (2001) Synthetic derivatives of abietic acid with radical scavenging ability. J Nat Prod 64:761-766
20. Thomas JR (1960) The identification of radical products from the oxidation of diphenylamine. J Am Chem Soc 82:5955-5956
21. Ferreira ICFR, Queiroz MJRP, Vilas-Boas M, Estevinho LM, Begouinb A, Kirsch G (2006) Evaluation of the antioxidant properties of diarylamines in the benzo[b]thiophene series by free radical scavenging activity and reducing power. Bioorg Med Chem Lett 16:1384-1387
22. Kurogi Y, Guner OF (2001) Pharmacophore modeling and threedimensional database searching for drug design using catalyst. Curr Med Chem 8:1035-1055
23. Debnath AK (2002) Pharmacophore mapping of a series of 2, 4-diamino-5-deazapteridine inhibitors of mycobacterium avium complex dihydrofolate reductase. J Med Chem 45:41-53
24. Kahnberg P, Howard MH, Liljefors T, Nielsen M, Nielsen EO, Sterner O, Pettersson I (2004) The use of a pharmacophore model for identification of novel ligands for the benzodiazepine binding site of the GABAA receptor. J Mol Graph Model 23:253-261
25. Faragalla J, Bremner J, Brown D, Griffith R, Heaton A (2003) Comparative pharmacophore development for inhibitors of human and rat 5-α-reductase. J Mol Graph Model 22:83-92
26. Ekins S, Bravi G, Wikel JH, Wrighton SA (1999) Three- dimensionalquantitative structure activity relationship analysis of cytochrome P-450 3A4 substrates. J Pharmacol Exp Ther 291:424-433 (Pubitemid 29451619)
27. Leonard JT, Roy K (2006) On selection of training and test sets for the development of predictive QSAR models. QSAR Comb Sci 25:235-251
28. Everitt B, Landau S, Leese M (2001) Cluster analysis. Arnold, London
29. Dougherty ER, Barrera J, Brun M, Kim S, Cesar RM, Chen Y, Bittner M, Trent JM (2002) Inference from clustering with application to gene-expression microarrays. J Comput Biol 9:105-126
30. Accelrys Inc. (2010) Cerius 2, v. 4.10. Accelrys Inc, San Diego
31. Smellie A, Teig SL, Towbin P (1995) Poling: promoting conformational variation. J Comput Chem 16:171-187
32. Roy K, Paul S (2009) Exploring 2D and 3D QSARs of 2, 4-diphenyl-1, 3-oxazolines for ovicidal activity against Tetranychus urticae. QSAR Comb Sci 28:406-425
33. Roy PP, Paul S, Mitra I, Roy K (2009) On two novel parameters for validation of predictive QSAR models. Molecules 14:1660-1701
34. Mitra I, Saha A, Roy K (2009) Quantitative structure-activity relationship modeling of antioxidant activities of hydroxybenzalacetones using quantum chemical, physicochemical and spatial descriptors. Chem Biol Drug Des 73:526-536
35. Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graph Mod 20:269-276
36. Roy PP, Roy K (2008) On some aspects of variable selection for partial least squares regression models. QSAR Comb Sci 27:302-313
37. Roy PP, Roy K (2008) Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors. Chem Biol Drug Des 72:370-382
38. Patrick GL (2009) An introduction to medicinal chemistry. Oxford University Press, New York
39. 1 agonists. http://accelrys.com/references/case-studies/archive/ studies/D1Agonists-full.html. Accessed on February 12, 2010
40. Hirashima A, Shigeta Y, Eiraku T, Kuwano E (2003) Inhibitors of calling behavior of Plodia interpunctella. J Insect Sci 3:4-12